CompletedPhase 3NCT01599923
Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation
Studying Scorpion envenomation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Principal Investigator
- Walter Garcia Ubbelohde, MDInstituto Bioclon
- Intervention
- Antivenin Centruroides (scorpion) equine immune F(ab')2(biological)
- Enrollment
- 29 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2005 – 2006
Study locations (1)
- Children's Hospital of Morelos, Cuernavaca, Morelos, Mexico
Collaborators
University of Arizona · Universidad Nacional Autonoma de Mexico
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01599923 on ClinicalTrials.gov